The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Feifei Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous, Biomarkers, Tumor. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Program of Zhejiang Province.
Abstract (Originalsprache)
Aim
Low‐grade serous ovarian cancer (LGSOC) is a rare subtype of ovarian cancer with distinct biological behavior. This study aimed to identify new biomarkers with potential diagnostic and prognostic value for LGSOC.
Methods
Gene‐expression data were downloaded from the Gene Expression Omnibus (GEO). Differentially expressed genes (DEGs) were identified using R. Functional enrichment analyses were conducted to determine the biological functions and signaling pathways associated with DEGs. The mitogen‐activated protein kinase (MAPK) pathway‐related gene, chromosome 1 open reading frame 106 ( C1orf106 ), was selected as the target gene. Immunohistochemistry and quantitative real‐time polymerase chain reaction (qRT‐PCR) were performed to verify its expression. Associations between C1orf106 expression and the clinical features of patients were analyzed using the chi‐square ( χ 2 ) test. Prognostic significance was evaluated with survival analyses.
Results
A total of 3099 upregulated and 4968 downregulated genes were identified in LGSOC. Gene set enrichment analysis (GSEA) demonstrated significant alterations in KRAS signaling and metabolic pathways between LGSOC and healthy controls. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses revealed enrichment in immune response and MAPK pathway alterations. Immunohistochemistry and qRT‐PCR confirmed that C1orf106 expression in LGSOC tissues was significantly higher than in normal ovarian tissues. Clinically, high C1orf106 expression was associated with lower BMI (< 25 kg/m 2 ), the absence of visible residual disease, and improved progression‐free survival (PFS) and overall survival (OS) in univariate Cox and Kaplan–Meier analyses.
Conclusions
C1orf106 may serve as a promising marker for the diagnosis and prognosis of LGSOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Obstetrics and Gynecology, Jiaxing University Affiliated Women and Children Hospital, Jiaxing, Zhejiang, China.
ORCID-Profile: Xuedong Tang, Xiaodong Cheng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Program of Zhejiang Province
- Science and Technology of the People's Livelihood Project of Jiaxing City
Zitieren
APA
Song, F., Chen, X., Zhang, T., Tang, X., & Cheng, X. (2025). The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70118
Vancouver
Song F, Chen X, Zhang T, Tang X, Cheng X. The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.70118
BibTeX
@article{Song2025,
author = {Song, Feifei and Chen, Xiaojing and Zhang, Tao and Tang, Xuedong and Cheng, Xiaodong},
title = {The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.70118}
}
EUVIMED